Advantagene, Inc.
Biotechnology company · Auburndale, Massachusetts, United States
Advantagene, Inc. is a biotechnology company headquartered in Auburndale, Massachusetts, United States. It has received 10 US government small-business research awards (SBIR/STTR) from health agencies, $12 million in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $29 million sold in a notice filed in 2018.
Advantagene at a glance
What does Advantagene do?
US government research funding
10 SBIR/STTR small-business research awards from US health agencies, $12.5 million in total (2003 to 2018). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $28.7 million sold (2018).
Frequently asked questions about Advantagene
Where is Advantagene headquartered?
Advantagene, Inc. is headquartered in Auburndale, Massachusetts, United States.
What does Advantagene do?
Advantagene, Inc. is a biotechnology company.
Similar companies
- Immunochem Therapeutics LLCAuburndale, Massachusetts, United States
- CereVasc, Inc.Auburndale, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences